Published in Hepatitis Weekly, February 2nd, 2009
Virus Strains in Just Three Days, Helping Physicians Treat Patients Quickly, Improve Patient Outcomes and Reduce Healthcare Costs
ViraCor Laboratories, the leader in molecular diagnostic testing for infectious diseases, announced the launch of a new cytomegalovirus (CMV) antiviral resistance test that provides diagnosis days faster than other tests on the market.
Developed in ViraCor's laboratories, the molecular test accurately detects key genetic mutations associated with antiviral resistance in CMV in three days or less. Turnaround time on most CMV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-02-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.